Evidence map›Paper›PMID 29391000›Full record

ArticleBMC complementary and alternative medicine2018

Computational investigations of physicochemical, pharmacokinetic, toxicological properties and molecular docking of betulinic acid, a constituent of Corypha taliera (Roxb.) with Phospholipase A2 (PLA2).

Mohammad Firoz Khan, Nusrat Nahar, Ridwan Bin Rashid, Akhtaruzzaman Chowdhury, Mohammad A Rashid

Open access · goldAbstract read
In one paragraph

Article in BMC complementary and alternative medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 71 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Phenolic Compounds ofBioMed research international · 2025
    Article
  5. Exploring the Inhibitory Potential ofTheScientificWorldJournal · 2024
    Article
  6. Docking, Synthesis, and ICurrent computer-aided drug design · 2024
    Article
  7. Article
  8. Antifungal Constituents ofMolecules (Basel, Switzerland) · 2023
    Article
  9. A Systematic Review ofLife (Basel, Switzerland) · 2023
    Review
  10. Article
  11. Heterocyclic chalcone (3 Biotech · 2023
    Article
  12. In silico Study of Antiviral Activity of Polyphenol Compounds fromAdvances and applications in bioinformatics and chemistry : AABC · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Screening for a Potential Therapeutic Agent from the Herbal Formula in the 4Evidence-based complementary and alternative medicine : eCAM · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mohammad Firoz KhanDepartment of Pharmacy, State University of Bangladesh, Dhaka, 1205, Bangladesh.
Nusrat NaharDepartment of Pharmacy, State University of Bangladesh, Dhaka, 1205, Bangladesh.
Ridwan Bin RashidDepartment of Pharmacy, State University of Bangladesh, Dhaka, 1205, Bangladesh.
Akhtaruzzaman ChowdhuryDepartment of Chemistry, Rajshahi University of Engineering and Technology, Rajshahi, Bangladesh.
Mohammad A RashidDepartment of Pharmaceutical Chemistry, University of Dhaka, Dhaka, 1000, Bangladesh. rashidma@du.ac.bd.
State University of Bangladesh · BDRajshahi University of Engineering and Technology · BDUniversity of Dhaka · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBetulinic acid (BA) is a natural triterpenoid compound and exhibits a wide range of biological and medicinal properties including anti-inflammatory activity. Therefore, this theoretical investigation is performed to evaluate (a) physicochemical properties such as acid dissociation constant (pKa), distribution coefficient (logD), partition coefficient (logP), aqueous solubility (logS), solvation free energy, dipole moment, polarizability, hyperpolarizability and different reactivity descriptors, (b) pharmacokinetic properties like human intestinal absorption (HIA), cellular permeability, skin permeability (P

methodsThe physicochemical properties were calculated using MarvinSketch 15.6.29 and Gaussian 09 software package. The pharmacokinetic and toxicological properties were calculated on online server PreADMET. Further, the molecular docking study was conducted on AutoDock vina in PyRx 0.8.

resultsThe aqueous solubility increased with increasing pH due to the ionization of BA leading to decrease in distribution coefficient. The solvation energies in water, dimethyl sulfoxide (DMSO), acetonitrile, n-octanol, chloroform and carbon tetrachloride were - 41.74 kJ/mol, - 53.80 kJ/mol, - 66.27 kJ/mol, - 69.64 kJ/mol, - 65.96 kJ/mol and - 60.13 kJ/mol, respectively. From the results of polarizability and softness, it was clear that BA is less stable and hence, kinetically more reactive in water. BA demonstrated good human intestinal absorption (HIA) and moderate cellular permeability. Further, BA also exhibited positive CNS activity due to high permeability through BBB. The toxicological study revealed that BA was a mutagenic compound but noncarcinogenic in mice model. Moreover, molecular docking study of BA with PLA2 revealed that BA interacts with GLY22 & GLY29 through hydrogen bond formation and LEU2, PHE5, HIS6, ALA17, ALA18, HIS47 and TYR51 through different types of hydrophobic interactions. The binding affinity of BA was - 41.00 kJ/mol which is comparable to the binding affinity of potent inhibitor 6-Phenyl-4(R)-(7-Phenyl-heptanoylamino)-hexanoic acid (BR4) (- 33.89 kJ/mol).

conclusionsOur computed properties may assist the development of analytical method to assay BA or to develop BA derivatives with better pharmacokinetic and toxicological profile.

Indexed as

Betulinic AcidChemical PhenomenaHydrogen-Ion ConcentrationMolecular Docking SimulationPentacyclic TriterpenesPhospholipases A2Protein BindingThermodynamicsTriterpenesBetulinic AcidPentacyclic TriterpenesPhospholipases A2TriterpenesCarcinogenicMolecular dockingPharmacokineticPhysicochemical propertiesPolarizabilitySolvation free energyToxicology

Identifiers

PMID29391000
PMCPMC5795847
OpenAlexW2795827485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.